Clinical Trial Update: The Study of the Crushing Technique Application Using SES in Coronary Bifurcations. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the crushing technique with sirolimus-eluting stents for coronary bifurcation lesions sponsored by Cordis; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-eluting stent (SES) (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED